Zullo Investment Group Inc. Sells 347 Shares of Colgate-Palmolive (NYSE:CL)

Zullo Investment Group Inc. lessened its stake in Colgate-Palmolive (NYSE:CLFree Report) by 11.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,810 shares of the company’s stock after selling 347 shares during the quarter. Zullo Investment Group Inc.’s holdings in Colgate-Palmolive were worth $255,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at $32,000. Hager Investment Management Services LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth about $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the 3rd quarter valued at about $42,000. Roxbury Financial LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $43,000. Finally, Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $49,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 1.1 %

CL opened at $87.32 on Thursday. The stock has a market cap of $70.86 billion, a price-to-earnings ratio of 24.81, a price-to-earnings-growth ratio of 4.10 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The firm’s fifty day moving average is $89.13 and its 200 day moving average is $96.05. Colgate-Palmolive has a fifty-two week low of $83.70 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the business earned $0.87 EPS. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.76 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analyst Ratings Changes

A number of brokerages recently weighed in on CL. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Finally, Morgan Stanley cut their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.16.

Get Our Latest Analysis on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.